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1 Introduction
Studying cellular response to radiation damage is important from the perspectives of
both radiotherapy and the mitigation of radiation damage. In the case of the former,
the goal is the induction of cell death, whereas in the latter case a cellular response
leading to organismal survival is required.
The fate of the organism after radiation damage is linked in a complex manner to
cellular fate. In the short term, an extensive cell death due to radiation damage will
lead to the death of the organism. In the long term (relevant only if the organism
survives the short term effects), it the survival of healthy and robust cells that dic-
tate the organism’s survival (for example, absence of long term cancerous cells). In
this manuscript, we focus on the immediate survival of the organism after radiation
damage.
The mechanism of cell death after radiation damage is purported to be apoptosis
via caspase activation that occurs several hours after radiation injury. Thus, it is
natural to investigate cellular apoptotic machinery. Cellular response to radiation is
very complex and involves, possibly, proteins that respond to DNA damage and the
formation of free radicals that modify cellular biochemistry. Although the exposure to
radiation may be momentary, the effect of the exposure on cellular biochemistry may
be long lived. Further, several proteins that are expressed transiently after radiation
damage, may trigger downstream response such as caspase activity that occurs long
after their expression.
In view of the complex cellular response, protein–protein interactions that lead
to that response, and possible importance of temporal evolution of the system, it is
important to study systemically the time-dependent cellular response to stress.
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There have been various efforts to model cellular response to radiation, as well as
to model apoptosis. Efforts to model cellular response to radiation were largely pre-
cipitated by the observation, at the level of a single cell, of oscillatory p53 response to
radiation damage.1 In particular, the oscillatory response of p53 to radiation damage
has been modeled mostly using deterministic simulations with kinetic rate laws,1–4
and, to a significantly lesser extent, via stochastic simulations.5 Cellular apoptosis
has been modeled, independent of p53 radiation response, via deterministic simula-
tions by several research groups,6–9 including efforts to include cell–cell variability in
a probabilistic manner.10,11
Recently, there have been a few efforts to link the p53 response to cell sur-
vival/death using deterministic simulations,12–14 or with inclusion of limited stochas-
ticity.15 Due to increasingly larger pool of experimental observation on the proteins
involved, and their cellular compartmentalization, in the apoptotic network, model-
ing of transient system behavior remains an active area of research and serves as a
platform for evaluating pharmacological strategies.
Spatio-temporal modeling using stochastic simulation methods allows for detailed
examination of the kinetics of biochemical reaction networks within a cell. From
such simulations, one can address several different issues: spatial localization of reac-
tions (e.g., on the mitochondrial membrane), as well as studying the time evolution
of molecular concentrations in response to perturbations to the system. These per-
turbations can be radiation stress on the cell, or the response to a given drug dose.
Further, stochasticity allows for the inclusion of cell variability in a natural way, as
well as for studying conditions where the number of certain types of molecules become
very low and their presence/absence dictates system behavior.
In this study, we perform stochastic simulations to study the time evolution of pro-
teins, associated with apoptotic pathways, in response to radiation damage. Further,
we check the efficacy of various treatment strategies, including polypharmacological
effects. In particular, we use different inhibitors targeting different proteins in the
reaction network. The manuscript is organized as follows. We first present the bio-
2
chemical reaction network, gathered from experimental observations, associated with
radiation induced apoptosis. Then, we describe briefly the stochastic simulations
that we perform to study cell response to radiation damage, followed by results and
discussion.
2 Biochemical reaction network
We present here the chain of biochemical events that we use to model apoptotic
mechanisms that are activated after radiation damage. Instead of adopting a com-
prehensive model that includes all the cellular processes that are activated, or affected,
by radiation damage, we focus on a number of key proteins/genes as a first approxi-
mation. An overview of the key interactions is given in Figure 1. Table 1 gives details
about the proteins involved in the system. Several other proteins besides those in
Figure 1 are included in the model and described in Table 1, since an interaction
map, such as that in Figure 1, does not contain details of the biochemical events that
lead to the individual interactions.
Before we describe the radiation response of the network, we present the generic
underlying network.
2.1 p53 module
p53 is an integral component of cell death due to genotoxic stress (including ra-
diation damage), and it activates apoptosis via both transcription–dependent and
transcription–independent pathways.16–18 The exact effect of p53 in its transcription-
independent role in apoptosis is still in-debate (see a recent review by Lindenboim et
al.19), we attempt to incorporate some of the key experimental observations.
The response of p53 to radiation exposure has been studied in great detail at
the individual cell level. The response of p53 to radiation determined experimentally
forms the starting point of our modeling effort: we first focus on the p53 “module”
(as highlighted in Figure 1 with the dashed rectangle) and calibrate our model to
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reproduce the known p53 response.
p53 exists in several forms in a cell based on its post-translational modifications
(e.g., phosphorylation, ubiquitination at different sites). In this manuscript, we utilize
a model that captures the known biological features: such as p53 oscillatory behavior
upon radiation damage,1,2,20 and a stress–induced increase in nuclear p5321 and its
transcriptional activity.22,23
p53 is translated in the cytoplasm (p53C) and this formation is represented by
Φ
κ1
−→ p53C (1)
where Φ represents a null state, and the above reaction represents the formation of
p53C under normal operating conditions given by the rate κ1.
p53C can translocate to the nucleus, especially when a cell undergoes stress.21
This translocation is modeled by
p53C
κ2
−→ p53n (2)
where p53n is the nuclear p53. In the nucleus, p53n transcriptionally activates Mdm2
mRNA and this transcription activation is modeled as cooperative:3 p53n tetramers
on the DNA leads to this transcription activation. The oligomerization of p53n is
depicted by
4p53n
k
+
3
−⇀↽−
k
−
3
p53no (3)
where the reaction order of the forward reaction is 4. The oligomerized p53 leads to
a direct transcription activation of Mdm2:
p53no
κ4
−→ p53no +Mdm2m (4)
The Mdm2 messenger RNA translocates to the cytoplasm where it is translated.
The cytoplasmic Mdm2 (Mdm2C) can be imported into the nucleus. This series of
events is described by the following reactions:
Mdm2m
κ5
−→ Mdm2mC (5)
4
Mdm2mC
κ6
−→ Mdm2C (6)
Mdm2C
κ7
−→ Mdm2 (7)
The monoubiquitinated, nuclear p53 (p53NU) is formed via the interaction of
p53n with Mdm2 (or similar ligases),24 and we represent this by
p53n +Mmd2
k
+
8
−⇀↽−
k
−
8
p53.Mdm2
κ8
−→ p53NU +Mdm2 (8)
A similar reaction is modeled to occur for the cytoplasmic p53 and Mdm2:
p53C +Mmd2C
k
+
9
−⇀↽−
k
−
9
p53C.Mdm2
κ9
−→ p53CU +Mdm2C (9)
Further, the ubiquitinated nuclear p53 can translocate to the cytoplasm:
p53NU
κ10
−→ p53CU (10)
The ubiquitinated cytoplasmic p53 can translocate to the mitochondria25 as shown
below:
p53CU
κ11
−→ p53m (11)
Upon severe genotoxic stress, p53n become transcriptionally active for pro-apoptotic
proteins23 such as PUMA and Bax, and such a transcriptionally active form is rep-
resented by p53T:
p53n
κ12
−→ p53T (12)
Although the major role of p53T is transcriptional activation of pro-apoptotic pro-
teins, we let it retain the capacity for oligomerizing and activating Mdm2 (this,
though, is a minor effect),
4p53T
k
+
13
−⇀↽−
k
−
13
p53To (13)
p53To
κ14
−→ p53To +Mdm2 (14)
The increase in p53 upon radiation damage is not expected to be a step function.
Similarly, return of p53 to baseline levels after removal of radiation source is not
expected to be instantaneous. Indeed, oscillatory levels of p53 persist for an extended
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period of time after radiation damage.2 Further, p53 response to radiation is mediated
by upstream proteins such as ATM. We do not model such upstream agents in specific
detail, instead we represent the upstream events by the following set of reactions.
Φ
k
+
15
−⇀↽−
k
−
15
A (15)
A
κ16
−→ A + B (16)
B
κ17
−→ Φ (17)
B
κ18
−→ B + p53C (18)
Thus, A activates B, which in turn activates p53C. The effect of these upstream
reactions is a smooth increase in p53C concentration after radiation damage.
In addition to the above equations, we model the independent degradation of
p53C, p53n, p53CU, p53NU, p53T, and p53m to highlight the fact that external
agents (i.e., those not modeled explicitly) have a role in modulating protein concen-
trations. For example, several E3-ligases (other than Mdm2) ubiquitinate and label
p53 for proteasomal degradation downstream. These reactions are given below:
p53C
κ19
−→ Φ (19)
p53n
κ20
−→ Φ (20)
p53CU
κ21
−→ Φ (21)
p53NU
κ22
−→ Φ (22)
p53T
κ23
−→ Φ (23)
p53m
κ24
−→ Φ (24)
2.2 p53 modulated apoptotic pathways
Now, we discuss the mitochondrial apoptotic pathways downstream of p53, and the
role of p53 module to the activation of mitochondrial apoptosis (see Figure 1).
6
p53T leads to transcription activation of proapoptotic PUMA and Bax, as modeled
by
p53T
κ25
−→ p53T + PUMA (25)
and,
p53T
κ26
−→ p53T + Bax (26)
The roles of PUMA and Bax are discussed below.
p53m binds to the anti-apoptotic protein Bcl-2 to inhibit the anti-apoptotic ac-
tion of Bcl-2 on the mitochondria.26 The biochemical equation associated with this
reaction is given by
p53m + Bcl-2
k+
27
−⇀↽−
k−
27
p53m.Bcl-2 (27)
with binding affinity given by k+27/k
−
27. PUMA also binds to the antiapoptotic Bcl-2
member on the mitochondrial membrane.27
PUMA + Bcl-2
k
+
28
−⇀↽−
k
−
28
PUMA.Bcl-2 (28)
Further, PUMA binds stronger to Bcl-2 than does p53, and can displace p53 from
its complex with Bcl-218 - as can be seen by a combination of reactions 27 and 28,
thus, freeing up p53 for further proapoptotic activity on the mitochondria, such as
by activating Bax/Bak as shown below.
Pro-apoptotic Bax translocates back and forth from the cytoplasm to the mito-
chondria28 to establish an equilibrium between the cytosolic and mitochondrial Bax
concentrations:
Bax
k
+
29
−⇀↽−
k
−
29
Baxmito (29)
At the mitochondria, Bax interacts with Bcl-2 to form a complex28 that prevents Bax
oligomerization:
Baxmito + Bcl-2
k
+
30
−⇀↽−
k
−
30
Baxmito.Bcl-2 (30)
Thus, the available Bcl-2 (that also forms complexes with p53 and PUMA as shown
above) regulates the amount of Bax available for oligomerization.
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Chipuk et al.27 reported that p53m binds stronger to Bcl-2 than does Bax, and
can displace Bax from its complex with Bcl-2. This reaction can be modeled via the
following reaction:
p53m + Baxmito.Bcl-2
k
+
31
−⇀↽−
k
−
31
p53m.Bcl-2 + Baxmito (31)
However, eq 31 is a straightforward linear combination of eqs 27 and 30, and, thus,
the obvious requirement of consistent equilibrium constants (k+31/k
−
31 = k
+
27k
−
30/k
−
37k
+
30)
must be observed (or, eq 31 should not be considered explicitly).
Active form of Bax on the mitochondrial membrane is needed for oligomeriza-
tion, a process that requires further interaction of Bax with activators such as tBid.
tBid localization to mitochondria29,30 is an important event for Bax activation and is
modeled by the following reaction:
tBid
k
+
32
−⇀↽−
k
−
32
tBidmito (32)
Subsequently, tBid activates mitochondrial Bax into an active (for oligomerization)
form:
tBidmito + Baxmito
κ33
−→ tBidmito + Bax
∗ (33)
It has also been suggested that tBid activates Bax in the cytosol which then localizes
to the mitochondria.31 However, the order of consecutive reactions is not expected to
have a significant effect further downstream (such as caspase activation). A similar
Bax (or Bak) activating effect can be achieved by p53m:18
p53m + Baxmito
κ34
−→ p53m + Bax∗ (34)
and by PUMA,32
PUMA + Baxmito
κ35
−→ PUMA + Bax∗ (35)
The activated Bax then oligomerizes on the mitochondrial membrane:
Bax∗ + Bax∗
k
+
36
−⇀↽−
k
−
36
Bax2 (36)
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Further, higher order oligomerization is modeled following Albeck et al.9
Bax2 + Bax2
k
+
37
−⇀↽−
k
−
37
Bax4 (37)
Mitochondrial outer membrane permeabilization (MOMP) induced by Bax oligomer-
ization results in the release of cytochrome-c from the mitochondria into the cyto-
plasm. We model the release of cytochrome-c via the following process:7
Bax4 + cytcmito
κ38
−→ Bax4 + cytc (38)
where the above reaction serves to model the fact that the presence of a Bax pore
is essential for release of cytochrome-c into the cytoplasm. Similarly, MOMP also
releases Smac/Diablo into the cytoplasm: these proteins bind to anti-apoptotic IAP’s
and, thus, facilitate apoptosis.33
Bax4 + Smacmito
κ39
−→ Bax4 + Smac (39)
Cytoplasmic cytochrome-c interacts with Apaf in an ATP-dependent manner, and
the heterodimer forms a heptameric complex called the “apoptosome”.34 Following
Bagci et al.7, we model these events via the following two reactions:
cytC + Apaf
k
+
40
−⇀↽−
k
−
40
cytC.Apaf (40)
7cytC.Apaf
k
+
41
−⇀↽−
k
−
41
apop (41)
Further, we use cooperativity in the formation of the apoptosome: the order of the
forward reaction 41 is 4.
The apoptosome then incorporates caspase-9, that in its autocatalyzed, activated
form cleaves procaspase-3 (C3) to form active caspase-3 (C3∗). Following Albeck et
al.,9 we use the following reactions for these processes:
apop + C9
k
+
42
−⇀↽−
k
−
42
apop.C9 (42)
apop.C9 + C3
k
+
43
−⇀↽−
k
−
43
apop.C3.C9
κ43
−→ apop.c9 + C3∗ (43)
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As mentioned above, tBid is an important factor for activation of the caspase
cascade. Caspase-8, activated due to external death signals, is an important molecule
responsible for Bid cleavage.35 Additionally, active caspase-3 also results in Bid cleav-
age, resulting in a positive feedback loop activating apoptosis.36 We model the asso-
ciated reactions following Bagci et. al.7:
C3∗ + Bid
k+
44
−⇀↽−
k
−
44
C3 ∗ .Bid
κ44
−→ C3∗ + tBid (44)
C8 + Bid
k
+
45
−⇀↽−
k
−
45
C8.Bid
κ45
−→ C8 + tBid (45)
The concentration of active caspase-8 depends on external death factors.
XIAP inhibits the activity of apoptosome37,38 and promotes proteasomal degra-
dation of caspase-339 preventing cell death. On the other hand, Smac inhibits the
activity of XIAP.33 These processes are modeled as,9
apop.C9 + XIAP
k
+
46
−⇀↽−
k
−
46
apop.C9.XIAP (46)
C3∗ +XIAP
k
+
47
−⇀↽−
k
−
47
C3∗.XIAP
κ47
−→ C3∗Ub +XIAP (47)
C9 + XIAP
k
+
48
−⇀↽−
k
−
48
C9.XIAP
κ48
−→ C9Ub +XIAP (48)
Smac + XIAP
k
+
49
−⇀↽−
k
−
49
Smac.XIAP (49)
In addition to above reactions, there are formation reactions for several species –
Bcl2, Bax, Apaf, C9, C3, XIAP, Smacm, cytcm, C8, and Bid. Further, these species,
along with C3*, C3U, C9U, Bax*, and p53 forms mentioned above also undergo
degradation reactions to help establish steady state.
3 Drug interactions
In this section, we integrate the possible drugs to regulate apoptosis in normal cells
into the biochemical network discussed above. In particular, we consider four specific
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proteins targets – Mdm2, PUMA, Bid, and C3∗ (Mdm2-I, PUMA-I, Bid-I, and C3-I,
respectively). The actions of the inhibitors are modeled by the following reactions:
Mdm2 +Mdm2 − I
k
+
50
−⇀↽−
k
−
50
Mdm2.Mdm2 − I, (50)
PUMA + PUMA− I
k
+
51
−⇀↽−
k
−
51
PUMA.PUMA − I, (51)
Bid + Bid− I
k
+
52
−⇀↽−
k−
52
Bid.Bid− I, (52)
and
C3∗ + C3 − I
k
+
53
−⇀↽−
k
−
53
C3∗.C3− I. (53)
Known inhibitors of p53/Mdm2 interaction includes nutlins, BEB55, BEB59,
and BEB69. Mustata et al.40 have identified several PUMA inhibitors using phar-
macophore modeling, and several of these compounds have been shown to inhibit
PUMA–induced apoptosis in vitro.
4 Stochastic simulation method
The number of proteins in a typical cell (about picoliter) are significantly less than
Avogadro’s number: a nanomolar concentration of a protein corresponds to ∼ 600
molecules of that protein in the cell. Accordingly, for smaller cells and/or lower con-
centrations, deterministic rate equations are not applicable. For this reason, we use
the well–known Gillespie algorithm for stochastic simulations of a system of chemical
reactions.
Details of the Gillespie Algorithm are given in the original papers.41,42 Here we
briefly describe some of the ideas behind the algorithm.
For illustration, consider the following schematic reaction,
A + B→ AB, (54)
and denote the stochastic rate constant by c. This stochastic rate is directly related
to the macroscopic kinetic rate, k, by a simple relation (which, for the reaction in eq 1
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is c = kV , where V is the reaction volume). At any instant of time, the propensity
for the reaction in eq 52 is
aα = NANBc (55)
where NA and NB are the number of molecules of A and B in the reaction volume,
and the subscript α denotes that the reaction index is α in the system of M chemical
reactions (1 ≤ α ≤M).
In the Gillespie algorithm, one such reaction is chosen to be proportional to its
propensity (we use the so-called Direct Reaction version), and the time is advanced
based on the overall reaction propensity at that time.41,42 The underlying assumptions
are that the system is in thermal equilibrium (the number of reactive collisions are
much less than the number of non-reactive collisions), and that it is well–mixed.
4.1 Heterogeneity
Real cellular systems are heterogeneous - e.g., mitochondria and cytoplasm offer vastly
different environments (and, there may be heterogeneities within these compartments
themselves). Thus, at a first glance, the well-mixed assumption of the Gillespie algo-
rithm seems to preclude an application to real cellular systems. However, Bernstein43
developed a protocol to extend the Gillespie algorithm to heterogeneous environments.
In that protocol,43 the cell (or, any simulation volume) is subdivided into elements
and a reaction is reproduced and treated as an individual reaction in each subvolume.
Accordingly, each reactant is treated as a different molecule in each subvolume (e.g.,
Ai 6= Aj , where i and j are different subvolumes), and the reaction propensities
are altered accordingly. Further, each subvolume is well–mixed – thus allowing for
formulating the system using the Gillespie algorithm. In context of this work, the
nucleus, the cytoplasm, and the mitochondrial membrane are well-mixed, distinct
subvolumes.
This protocol results in an increase in the number of reactions both due to the fact
that each reaction is treated independently in different subvolumes, as well as addi-
12
tional “reactions” (due to diffusion) relating to the conversion of Ai to Aj , as described
in detail by Bernstein.43 Based on the identity of a compartment/subvolume, a type
of protein may not be present in that compartment (for example, the apoptosome
does not permeate through the mitochondrial membrane).
5 Model parameters
We obtain several parameters from experimental results, and obtain others in the
range of previous computational studies.7,9 Here we discuss some known experimental
rate/equilibrium constants, and the initial concentrations of the species involved in
the biochemical reaction network discussed above.
The dissociation constant, k−27/k
+
27, for p53 and pro-apoptotic Bcl-2 family mem-
bers have been given variously as 160 nM27 and 535 nM26 – both obtained via surface
plasmon resonance. We choose an intermediate value of the dissociation constant
(333 nM). PUMA binds significantly more strongly, and Chipuk et al.27 report the
dissociation constant k−28/k
+
28 = 10 nM, a value that we use.
Edlich et al.28 report the on and off rate of Bax from cytosol and mitochondria
as approximately the same, and establish a first order reaction (as represented by
reaction 3) with k+29 = 4.9× 10
−3 s−1 and k−29 = 4.7× 10
−3 s−1.
For reaction 31, it is reported that p53 displaces Bax from its complex with Bcl-2
at equimolar concentration, whereas Bax displaces p53 from its complex with Bcl-2
at a 50 times higher concentration.18 This implies that k+31/k
−
31 = 50. Since eqs 27,
30, and 31 are not independent, the above stated values imply that k−30/k
+
30 ≈ 17 µM.
This value of dissociation constant is significantly higher than values reported in the
literature (0.1 µM44 and 20 nM45). We use k−30/k
+
30 nM, except where noted explicitly
– and, as shown below, the results obtained are robust to a wide range of values for
this dissociation constant.
Half lifes of a few proteins have also been reported in vivo. However, the direct use
of such an information (for example, to compute the decay rates of the type A→ Φ)
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is often not appropriate because the decay rate of protein A in vivo is convoluted
with, for example, the decay of protein B that upregulates A.
The parameters for the p53 module that differ for these three levels of radiation are
given in Table 2, and the parameters that stay the same irrespective of the radiation
level are given in Table 3. These parameters for the p53 module are chosen to reflect
p53 oscillations observed experimentally. κ11 and κ12 do not affect the dose-dependent
oscillatory behavior of p53, however, they are important for coupling of the p53
module to the apoptotic network, and the corresponding values are given in the text
and figures below.
5.1 Initial concentrations
When a normally unstressed cell is exposed to radiation, it undergoes a sequence of
biochemical events that may, depending upon the radiation dose, lead to apoptosis.
Thus, the appropriate initial conditions of cellular protein levels for such an apoptotic
study are the steady state conditions in an unstressed cell.
Irrespective of what initial number of molecules we start with, we first allow the
system to establish a normal steady state (without radiation–induced apoptosis) by
selecting N-IR kinetic parameters from Table 2 (in addition to radiation–independent
kinetic equations/parameters). Subsequently, we perturb the system with radiation
damage (modeled here as genotoxic effect), and allow the system to evolve. With
enough stress, the system will eventually display apoptosis, with a high concentra-
tion of pro-apoptotic proteins (such as active caspase-3). In essence, the initial con-
centrations that are used to study radiation induced damage and subsequent drug
treatments are the steady state conditions without any radiation/drug.
For reference, the typical concentration a typical protein present in the cell under
normal conditions is 10–100 nm.9 In a picoliter cell, the number of molecules of a
typical protein is, thus, in the range 6000–60000. On the other hand, proteins such as
active caspase-3 (C3∗) are expected to be low under normal homeostatic conditions.
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5.2 Modeling radiation damage
Mitochondrial apoptosis is regulated by transcription–dependent and independent
role of p53. Thus, we focus on the p53 module (Figure 1) to model the effects of
radiation damage. The downstream action of the apoptotic pathways (for example,
represented by Bax oligomerization, cleavage of caspase-3) occur due to the response
of the p53 module to radiation damage. Specifically, we model the response of p53 to
three different radiation levels: no radiation (N-IR), low radiation (L-IR), and high
radiation dose (H-IR).
The procedure for the simulation is as follows. (1) Establish steady state for an
unstressed cell (N-IR). (2) induce radiation damage (L-IR or H-IR), as modeled by
use of the appropriate kinetic parameters from Table 2 for a certain time ∆T . (3)
Return to unstressed parameters after ∆T .
We note here that ∆T does not refer to the time duration of radiation exposure,
rather it refers to the amount of time the radiation modifies the kinetic parameters.
∆T only indirectly refers to the exposure time: longer exposure to a given radiation
dose will affect cellular biochemical kinetics for a longer duration.
6 Results
6.1 Radiation induced p53 oscillations
Single–cell experiments to monitor cellular p53 levels after radiation damage showed
that individual cells show dramatic oscillations in p53 levels. In particular, these
oscillations are sustained and show dose-dependent oscillation frequencies.2 These
experimentally observed results form the basis of simulating the p53 module using
stochastic simulations: we reproduce the radiation dependent behavior of p53 re-
sponse using stochastic simulations.
Figure 2 shows the oscillations in p53n (the major p53 component upon radiation
damage) as a function of time for two different radiation doses and exposures. The
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chosen model for radiation damage reproduces the known p53 oscillations, that are
dependent upon the radiation dose. At low levels, this frequency is ≈ 11 hr, whereas
it decreases to ≈ 6 hr upon increasing the radiation dose.
The differences in L-IR and H-IR parameters for the p53 module suggests one
possible mechanisms for the observed radiation-dose dependent frequencies. Impor-
tant factors in the model leading to this difference are the enhanced translocation of
Mdm2 protein from the cytoplasm to the nucleus, and the enhanced translocation of
Mdm2 mRNA from the nucleus to the cytoplasm. This was deliberately chosen to
represent the time delay in Mdm2 response that is frequently utilized in deterministic
models.3,46,47
Thus, this study shows that such time delay can be modeled mechanistically in
stochastic simulations (and allow for the modulation of oscillation frequency) by the
realization that proteins/genes act in specific cellular contexts. Further, the increase
in the translocation rate of the Mdm protein (along with increased translocation of
p53) to the nucleus upon DNA damage has been suggested.48
Further, as Figure 2 suggests, at low exposure time (modeled by ∆T = 2×104 s),
there is a single peak in the p53 profile for both radiation levels. On the other hand,
sustained p53 oscillations are obtained for high exposure times (∆T = 2×105s). Even
for cells exposed to radiation for the same amount of time, it is possible that cell–cell
variability can lead to different amounts of observed oscillatory peaks (∆T is, after
all, not the radiation exposure time, but is the time for which the kinetic parameters
are altered from unstressed levels).
6.2 Role of p53 oscillations in apoptosis
At higher radiation dosage, the oscillations in p53 occur at a higher frequency. How-
ever, it is unclear if cellular apoptotic response is mainly determined by the oscillation
frequency: is increased apoptosis at higher dose of radiation a direct result of the
higher p53 oscillation frequency?
To address this question, we compare the caspase 3 activity obtained via the use
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of H-IR and L-IR parameters in Table 2, along with the kinetic parameters associated
with the rest of the apoptotic machinery. Further, we use the same rates for apoptosis-
related transcriptional activation of p53 (κ12 = 10
−5 s−1), and for p53 translocation
to mitochondrial membrane (κ11 = 10
−5 s−1). The obtained caspase-3 concentrations
for a cell are shown in Figure 3 for both H-IR and L-IR sets.
Upon using a radiation-dose independent coupling of the p53 module with the
apoptotic network, L-IR leads to an increase in caspase-3 activity upon radiation
damage (radiation damage occurs at t = 0). On the other hand, H-IR leads to low
caspase-3 concentration. Clearly, this result is at odds with experimental observation
– increased radiation dose leads to an increase in apoptosis. Correspondingly, if κ11
and/or κ12 are increased for H-IR, caspase-3 activity is increased (shown in Figure 3).
A crucial insight that emerges from Figure 3 is that the dose-dependent radiation
damage and cell death depend upon the coupling of the regulatory p53 module to the
apoptotic machinery (defined via an increase in the p53 pro-apoptotic transcriptional
activity, κ12, and an increase in p53 translocation to the mitochondria, κ11), and not
merely on the p53-oscillation frequencies. We use the term “coupling” to describe
how the p53-regulatory module leads to apoptosis via transcription-dependent (κ12)
and transcription-independent (κ11) pathways.
6.3 Downstream apoptosis cascade
The response of the apoptotic network downstream of the p53 module sheds further
light on the role of pro- and anti-apoptotic proteins in the cell. Here, we discuss
(i) oscillations downstream of p53, (ii) role of Bax–Bcl-2 interactions, and (iii) the
requirement for sufficient Bid cleavage for sustained apoptosis.
Figure 4 shows the concentrations of PUMA, Bax∗, tBid, and caspase-3 after
radiation damage with high dose (the qualitative response of low radiation dose is
similar).
PUMA mirrors the p53 oscillations, irrespective of the coupling strength. This
phenomenon is due to direct activation of PUMA by p53T. Unlike oscillations in
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PUMA level, oscillations in the concentration of activated Bax show a distinct de-
pendence on the coupling strength: at low coupling strength (no apoptosis), Bax
oscillations are sustained, but decay along with PUMA oscillations. On the other
hand, a high coupling that results in apoptosis leads to a sustained increase in ac-
tivated Bax at the expense of oscillations. Bax∗ increases initially due to the direct
action of PUMA on Bax. This leads to the release of caspase-3 that cleaves tBid
resulting in further Bax activation and a positive feedback loop.
A sustained caspase-3 activity even after the decay of PUMA depends upon
whether sufficient tBid is activated by the time PUMA decays. A sustained release
of tBid and the positive feedback is very important for sustained caspase activity:
for low coupling of p53 module and apoptotic network, insufficient PUMA activity
results in an insufficient amount of caspase 3 release and tBid activation to maintain
a sustained caspase activity.
6.3.1 Strength of interaction between Bax and Bcl-2
In Section 5, we discussed the strength of Baxm and Bcl-2 interactions (k−30/k
+
30): dif-
ferent values of this dissociation constant (either directly or indirectly) are suggested
by different groups spanning several orders of magnitude.18,44,45 Here, we discuss the
effect of a range of this dissociation constant on the apoptosis model we use in this
manuscript.
Figure 5 shows caspase-3 and Baxm.Bcl-2 concentrations for two different values
of the dissociation constants. A comparison of panels (a) and (c) shows that the
downstream apoptotic activity is unaffected by dissociation constants that differ by
two orders of magnitude (all other model parameters remain unchanged between these
two panels): caspase-3 concentration is unaffected, although vastly differing amounts
of Baxm.Bcl-2 complex are formed. Similarly, the different dissociation constants had
an insignificant effect on systems showing a lack of apoptosis (panels (b) and (d)).
The model is, thus, robust with respect to the strength of Baxm and Bcl-2 in-
teraction. This suggests that cells can exhibit significantly differing strengths of this
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interaction without affecting the cell fate given a genotoxic insult, and several alter-
nate mechanisms can lead to the same cell fate.
6.4 p53 transcription-independent apoptosis
So far, we have discussed p53 transcription dependent apoptosis via transcriptional
upregulation of PUMA and Bax upon radiation damage. On the other hand, the role
of p53 in a transcriptionally independent manner is also of importance. In its tran-
scription independent role, it has been suggested that p53 in the cytoplasm can either
directly activate Bax, or can indirectly activate Bax by binding to anti-apoptotic Bcl-
2 and, thus, preventing the latter’s anti-apoptotic action. In this section, we explore
this issue.
Figure 6 shows the evolution of p53m (top panel) and caspase-3 (bottom panel)
with time upon exposure to H-IR for different ratios of transcription dependent (κ12)
and independent (κ11) apoptosis pathway strengths. In the figure, the black line
represents the case where the strength of transcription dependent pathways alone is
not sufficient to cause apoptosis. Upon an increase in κ11 (black, red, and blue lines
– in that order), p53m shows an increasingly upregulated behavior. Correspondingly,
caspase-3 shows a sustained activity with an increase in p53 transcription independent
pathway strength (for the same κ12).
Strikingly, the removal of direct Bax activation by mitochondrial p53 (green line)
results in complete absence of apoptosis for the p53 transcription-independent apop-
tosis, even for a high strength of transcription independent pathway. This suggests
that the indirect role of p53m in apoptosis by binding Bcl-2 is not sufficient for sus-
tained apoptosis by the p53-transcription independent mode – direct Bax activation
by the mitochondrial p53 appears to be critical, too.
19
6.5 Role of inhibitors of specific proteins
From a pharmacological viewpoint, it is important to identify protein targets that are
good candidates for drug treatment to mitigate radiation damage. In this section, we
focus on this issue with the aim of identifying potential targets suitable for treatments
that are effective even if not administered immediately.
Figure 7 illustrates the efficacy of treatments administered after two different de-
lays: treatments administered immediately after radiation damage (15 minute delay,
top panel), and treatments administered after a longer delay (12 hours, bottom panel).
The radiation dose in Figure 7 leads to sustained caspase-3 activity in absence of drug
treatment (bottom panel of Figure 4, blue curve).
If treatment is available immediately after radiation damage, inhibition of PUMA
is very effective in mitigating radiation damage. Similarly, inhibition of Bid also helps
in mitigating radiation damage (although to a lesser extent than PUMA inhibition).
In contrast, treatment via inhibition of Mdm2 and caspase-3 are not effective. On the
other hand, if there is a longer delay before treatment is administered, PUMA inhibi-
tion is an ineffective treatment and inhibition of Bid is the most effective treatment.
The ineffectiveness of PUMA inhibition in this case results because PUMA activity
till the administration of PUMA-I leads to sufficient activation of positive feedback
loop involving caspase-3 and Bid: activation of Bax via tBid dominates the apoptotic
response at this late stage.
The main cause of apoptosis for the system in Figure 7 is the p53-transcription
dependent pathway. Thus, Mdm2 inhibition, that decreases the ubiquitination of
p53n and, subsequently, leads to an increase in p53T (and PUMA and Bax), increases
the propensity of the system to undergo apoptosis. A comparison of the two panels
of Figure 7 shows that administering Mdm2-I sooner after radiation damage leads to
a quicker increase in caspase-3 activity.
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7 Discussion
7.1 Testable hypotheses
Several key, testable features of cellular response to apoptosis emerges from the model
and are listed as following. (i) oscillatory response of PUMA, at the level of a single
cell, to radiation damage, (ii) elevated tBid activity even after PUMA decays when an
increase in apoptosis occurs, and (iii) inhibition of Bid is more effective in mitigating
radiation damage than PUMA inhibition when the treatment is administered after a
substantial delay.
The last point is especially relevant with respect to developing a treatment strategy
for mitigating radiation damage. Even a very potent inhibitor of PUMA may not
prevent apoptosis when it is administered after a substantial delay. Indeed, the
inhibitor used in the current model acts in nM concentrations, and despite being
effective when administered immediately after radiation damage, is ineffective after a
longer delay because of enough tBid activity to maintain a sustained caspase activity.
Even if potent inhibitors of Bid are not currently known, it is possible to test the
last hypothesis above using the following two approaches. Firstly, a si-RNA knockout
of PUMA performed several hours after radiation damage should be ineffective in
mitigating apoptosis due to radiation damage. Secondly, knocking out Bid several
hours after radiation damage should be more effective in mitigating apoptosis due to
radiation damage.
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Figure 1: A map of interactions in the apoptotic pathway. This map only shows a
schematic of the interactions highlighting the main features of the model. Detailed
biochemical reactions (that may involve proteins not specifically mentioned in this
map) are given the text.
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Figure 2: Sustained oscillations in p53 concentration as a result of the duration of
alteration, via radiation, of cellular biochemical kinetics. Radiation damage at t = 0
leads to radiation–dose dependent p53 oscillations. Single spikes in p53 concentrations
(the left two panels) are observed when radiation induces a momentary change in
cellular biochemical kinetics, and sustained oscillations (the two panels on the right),
occur when the cellular biochemical kinetics are altered for a longer duration. Further,
the frequencies of oscillations at the two radiation dosage (top right and bottom right
panel) are similar to the experimentally observed values.
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Figure 3: An increase in pro-apoptotic transcriptional activity of p53 associates with
higher radiation dose to induce apoptosis. Caspase activities induced by the higher
radiation dose for two different pro-apoptotic transcriptional activity of p53 (κ12). A
lower dose of radiation leads to a substantial caspase activity at a smaller value of
κ12. κ11 = 10
−5 for the three cases.
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Figure 4: Role of tBid activation for sustained caspase-3 activity. A comparison of
the concentrations of PUMA, caspase-3, and tBid obtained after irradiation with a
high dose at t = 0 with two different couplings (κ12) – low value of κ12 in the top
panel does not lead to enough tBid activity to sustain apoptotic activity. κ11 = 10
−5
for both panels.
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Figure 5: Robustness of the model (for caspase-3 activity) with respect to the strength
of Baxm and Bcl-2 interactions. Panels (a) and (c) show the results for κ12 = 2 ×
10−5 s−1 showing distinct apoptosis despite vastly different strengths of Baxm and
Bcl-2 interaction. Panels (b) and (d) show an absence of apoptosis for different
strengths of Baxm–Bcl-2 interactions (and both are for κ12 = 10
−5 s−1.
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Figure 6: Important role of direct Bax activation by mitochondrial p53 in inducing
apoptosis via the p53 transcription-independent pathway. The top panel shows the
mitochondrial p53 concentrations for different sets of (κ11,κ12) values, and the asterix
for the green curve indicates that direct Bax activation by the mitochondrial p53 in
this case is abrogated (κ34 = 0). The bottom panel shows the corresponding C3
∗
concentrations.
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Figure 7: Effective mitigation of radiation damage via Bid inhibition at longer times.
The top panel shows caspase-3 activity upon treatment via Mdm2, PUMA, caspase-
3, and Bid inhibition after treatment by the respective inhibitors 15 minutes after
radiation damage, and the bottom panel shows caspase-3 activity after treatment
administered 12 hours after radiation damage. In the top panel, caspase-3 activity
after treatment with PUMA inhibitors (PUMA-I) is indistinguishable from zero. In
the bottom panel, resulting caspase-3 activity after treatment by PUMA-I (red line)
is similar to the activity after treatment by procaspase inhibitors (blue line).
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Table 1: List of proteins in Figure 1 and their descriptions.
symbol description
p53n nuclear p53
p53T stress–induced p53 for apoptotic activation
p53C p53 in cytoplasm
p53CU ubiquitinated p53 in cytoplasm
p53NU ubiquitinated p53 in nucleus
p53U polyubiquitinated p53 for proteasomal decay
p53m mitochondrial p53
p53no p53n oligomer for transcription activation of Mdm2
p53To p53T oligomer for transcription activation pro-apoptotic PUMA/Bax
Mdm2-mRNA mRNA of Mdm2
Mdm2n Mdm2/E3 ligase proteins in nucleus
Mdm2C Mdm2/E3 ligase proteins in cytoplasm
PUMA p53-upregulated modulator of apoptosis
Bcl-2 anti-apoptotic Bcl-2 family proteins
Bax proapoptotic Bcl-2 family members
Baxn oligomerized pro-apoptotic Bcl-2 family proteins
Baxm proapoptotic Bcl-2 members on the mitochondria
Bid BH3-only pro-apoptotic proteins
tBid truncated Bid
cytc cytoplasmic cytochrome c
Smac cytoplasmic Smac protein
Apaf Apaf-1 pro-apoptotic protein
XIAP IAP-family proteins
apop apoptosome
C9 caspase 9
C3 procaspase 3
C3∗ active caspase 3
C3U ubiquitinated caspase 3
C8 caspase 8
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Table 2: Radiation dose dependent kinetic parameters for the p53 module. κ11 and κ12
are also dose dependent, but their values do not affect the observed, dose–dependent
p53 oscillatory behavior and are noted in the text and the figures.
No radiation (N-IR) Low radiation (L-IR) High radiation (H-IR)
κ2 (s
−1) 10−4 10−4 10−3
κ5 (s
−1) 2× 10−4 2× 10−4 5× 10−3
κ7 (s
−1) 10−4 10−4 5× 10−4
k+15 (µM/s) 0 2× 10
−7 5× 10−7
κ20 (s
−1) 10−4 10−4 10−5
κ23 (s
−1) 10−4 10−4 10−5
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Table 3: Kinetic parameters of the p53 module that are unaffected by radiation.
Formation reactions: µMs−1
κ0 = 10
−6
Unimolecular reactions: s−1
k−3 = 10
−4 κ4 = 10
−1 κ6 = 5× 10
−4
k−8 = 0 κ8 = 10
−3 k−9 = 0
κ9 = 10
−3 κ10 = 10
−4 κ11 = 10
−5
k−13 = 10
−4 κ14 = 0.1 k
−
15 = 5× 10
−5
κ16 = 10
−2 κ17 = 0.1 κ18 = 10
−2
κ19 = 10
−4 κ21 = 10
−3 κ22 = 10
−3
κ24 = 10
−3
Bimolecular reactions: µM−1s−1
k+8 = 0.1 k
+
9 = 0.1
Special (cooperative) reactions
k+3 = 10 µM
−3s−1 k+13 = 10 µM
3s−1
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Table 4: Kinetic parameters downstream of the p53 module.
Formation reactions: µMs−1
10−5 for Bax, Bcl-2, Bid
10−4 for Apaf, C9, C3, XIAP, Smacm, cytc
Unimolecular reactions: units s−1
κ25 = 10
−3 κ26 = 10
−3 k−27 = 10
−3
k−28 = 10
−3 k+29 = 5× 10
−3 k−29 = 5× 10
−3
k−30 = 10
−3 k+32 = 5× 10
−3 k−32 = 5× 10
−3
k−36 = 10
−3 k−37 = 10
−3 k−40 = 10
−3
k−41 = 10
−5 k−42 = 10
−4 k−43 = 10
−4
κ43 = 1 k
−
44 = 10
−3 κ44 = 1
k−45 = 10
−3 κ45 = 1 k
−
46 = 10
−4
k−47 = 10
−3 κ47 = 0.1 k
−
48 = 10
−3
κ48 = 0.1 k
−
49 = 10
−3
10−3: PUMA, tBid, Bid, C3, C9, XIAP, Apaf
10−3: cytcm, Smacm, Smac, C3∗, C3U, C9U
10−3: Bax, Bax∗, Bcl2
5× 10−4: Mdm2, Mdm2C
10−2: cytC
Bimolecular reactions: µM−1s−1
k+27 = 3× 10
−3 k+28 = 0.1 k
+
30 = 0.6
k+31 = 1.0 k
−
31 = 2× 10
−2 κ33 = 0.5
κ34 = 5× 10
−2 κ35 = 0.5 k
+
36 = 0.6
k+37 = 0.1 κ38 = 10 κ39 = 10
k+40 = 0.3 k
+
42 = 3× 10
−2 k+43 = 3× 10
−2
k+44 = 0.3 k
+
45 = 0.3 k
+
46 = 3× 10
−2
k+47 = 1 k
+
48 = 1 k
+
49 = 0.1
Special (cooperative) reactions
k+41 = 10
5 µM−33s−1
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